Ashford Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Ashford Capital Management Inc

$678 Million
Q1 2024

A detailed history of Ashford Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ashford Capital Management Inc holds 8,400 shares of VRTX stock, worth $3.98 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

8,400

Previous 9,356 10.22%

Holding current value

$3.98 Million

Previous $3.81 Million 7.75%

% of portfolio

0.52%

Previous 0.55%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $389,751 - $426,452	-956 Reduced 10.22%	8,400 $3.51 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $1.13 Million - $1.35 Million	3,299 Added 54.47%	9,356 $3.81 Million
Q3 2023 Nov 15, 2023	SELL	$338.18 - $362.46 $142,035 - $152,233	-420 Reduced 6.48%	6,057 $2.11 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $33,328 - $37,302	-106 Reduced 1.61%	6,477 $2.28 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $1,982 - $2,261	7 Added 0.11%	6,583 $2.07 Million

Q4 2022 Feb 15, 2023	SELL	$285.76 - $321.48 $47,721 - $53,687	-167 Reduced 2.48%	6,576 $1.9 Million
Q3 2022 Nov 15, 2022	SELL	$273.83 - $305.53 $674,169 - $752,214	-2,462 Reduced 26.75%	6,743 $1.95 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $1,879 - $2,340	-8 Reduced 0.09%	9,205 $2.59 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $120,452 - $141,967	-544 Reduced 5.58%	9,213 $2.4 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $277,551 - $350,369	1,568 Added 19.15%	9,757 $2.14 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $214,584 - $240,137	1,183 Added 16.89%	8,189 $1.49 Million
Q2 2021 Aug 26, 2021	SELL	$187.49 - $221.1 $78,745 - $92,862	-420 Reduced 5.66%	7,006 $1.41 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $355,453 - $414,329	1,717 Added 30.08%	7,426 $1.6 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $45,335 - $60,463	219 Added 3.99%	5,709 $1.35 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $92,289 - $109,419	-361 Reduced 6.17%	5,490 $1.49 Million
Q2 2020 Aug 17, 2020	BUY	$225.48 - $295.8 $194,589 - $255,275	863 Added 17.3%	5,851 $1.7 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $45,547 - $56,500	228 Added 4.79%	4,988 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $333 - $447	2 Added 0.04%	4,760 $1.04 Million
Q3 2019 Nov 15, 2019	BUY	$166.23 - $187.09 $159,747 - $179,793	961 Added 25.31%	4,758 $806,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $62,708 - $74,570	-383 Reduced 9.16%	3,797 $698,000
Q3 2018 Nov 15, 2018	BUY	$167.73 - $192.74 $701,111 - $805,653	4,180 New	4,180 $806,000

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.

Account

Ashford Capital Management Inc Vertex Pharmaceuticals Inc Transaction History